These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24030672)

  • 1. Anticoagulant treatment is effective in atrial fibrillation.
    Robson JP; Lip GY
    BMJ; 2013 Sep; 347():f5429. PubMed ID: 24030672
    [No Abstract]   [Full Text] [Related]  

  • 2. Bad medicine: atrial fibrillation.
    Spence D
    BMJ; 2013 Aug; 347():f4910. PubMed ID: 23924656
    [No Abstract]   [Full Text] [Related]  

  • 3. Author's reply to Robson and Lip.
    Spence D
    BMJ; 2013 Sep; 347():f5431. PubMed ID: 24030673
    [No Abstract]   [Full Text] [Related]  

  • 4. Stroke prevention in atrial fibrillation.
    Freedman B; Potpara TS; Lip GY
    Lancet; 2016 Aug; 388(10046):806-17. PubMed ID: 27560276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stroke risk stratification in atrial fibrillation: oral anticoagulant therapy and bleeding risk in the elderly].
    Poli D; Grifoni E
    Recenti Prog Med; 2011 Jan; 102(1):23-7. PubMed ID: 21516668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
    Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles?
    Wong CW
    Hong Kong Med J; 2016 Dec; 22(6):608-15. PubMed ID: 27920399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant use in nonvalvular atrial fibrillation. Determining risk and choosing the safest course.
    Gornick CC
    Postgrad Med; 2000 Aug; 108(2):113-6, 119-21, 125-6. PubMed ID: 10951751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving role of stroke prediction schemes for patients with atrial fibrillation.
    Ha A; Healey JS
    Can J Cardiol; 2013 Oct; 29(10):1173-80. PubMed ID: 23932011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.
    Hylek EM; Becker RC
    Ann Neurol; 2008 Nov; 64(5):480-3. PubMed ID: 19067369
    [No Abstract]   [Full Text] [Related]  

  • 11. [Atrial fibrillation as a relevant risk factor for stroke].
    Porebska A; Nowacki P
    Neurol Neurochir Pol; 2005; 39(2):134-40. PubMed ID: 15871059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
    Keskar V; McArthur E; Wald R; Harel Z; Zimmerman D; Molnar AO; Garg AX; Lam NN; McCallum MK; Bota SE; Perl J; Sood MM
    Kidney Int; 2017 Apr; 91(4):928-936. PubMed ID: 28017326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation in atrial fibrillation and flutter.
    Scholten MF; Thornton AS; Mekel JM; Koudstaal PJ; Jordaens LJ
    Europace; 2005 Sep; 7(5):492-9. PubMed ID: 16087116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?
    Baruch L; Gage BF; Horrow J; Juul-Möller S; Labovitz A; Persson M; Zabalgoitia M
    Stroke; 2007 Sep; 38(9):2459-63. PubMed ID: 17673721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and stroke.
    Parnetti L; Gallai V
    Cerebrovasc Dis; 2000; 10 Suppl 4():40-1. PubMed ID: 11070400
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation.
    Hsu JC; Chan PS; Tang F; Maddox TM; Marcus GM
    Am J Med; 2015 Jun; 128(6):654.e1-654.e10. PubMed ID: 25554371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 18. Stroke prevention in atrial fibrillation.
    Waldo AL
    JAMA; 2003 Aug; 290(8):1093-5. PubMed ID: 12941684
    [No Abstract]   [Full Text] [Related]  

  • 19. [Risk stratification tools for evaluating thromboembolic risk in atrial fibrillation].
    Ouardiri Y; Marti C; Carballo S; Garin N
    Rev Med Suisse; 2011 Feb; 7(280):313-6, 318-9. PubMed ID: 21381276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which risk factors are more associated with ischemic stroke than intracerebral hemorrhage in patients with atrial fibrillation?
    McGrath ER; Kapral MK; Fang J; Eikelboom JW; ó Conghaile A; Canavan M; O'Donnell MJ;
    Stroke; 2012 Aug; 43(8):2048-54. PubMed ID: 22618379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.